mibefradil has been researched along with Cardiovascular Stroke in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (77.78) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, Y; Fujiwara, M; Harada, M; Kinoshita, H; Kuwabara, Y; Kuwahara, K; Murakami, M; Nakagawa, Y; Nakanishi, M; Nakao, K; Takano, M; Ueshima, K; Yasuno, S | 1 |
| Bitterling, H; Cleutjens, J; Daemen, MJ; Dorenkamp, M; Penz, S; Reinecke, A; Simon, R; Storz, C; Unger, T; Xia, QG | 1 |
| Blanc, T; Richard, V; Thuillez, C; Tron, C | 1 |
| Reimer, KA; Schwartz, LM; Vander Heide, RS | 1 |
| Habib, G | 1 |
| van Zwieten, PA | 1 |
| Chung, O; Daemen, MJ; Illner, S; Jänichen, G; Rossius, B; Sandmann, S; Spitznagel, H; Unger, T; Xia, QG | 1 |
| Backenköhler, U; Dörge, H; Heusch, G; Jalowy, A; Post, H; Schulz, R; Vahlhaus, C | 1 |
| Baxter, GF; Gadgil, S; Mocanu, MM; Yellon, DM | 1 |
| Boyden, PA; Gainullin, RZ; Pinto, JM; Rosen, MR; Sosunov, EA | 1 |
| Boutjdir, M | 1 |
| Meissner, A; Min, JY; Sandmann, S; Simon, R; Unger, T | 1 |
| Meissner, A; Min, JY; Sandmann, S; Unger, T | 1 |
| Bohle, RM; Dreyer, T; Sandmann, S; Unger, T | 1 |
| Claas, R; Cleutjens, JP; Daemen, MJ; Sandmann, S; Unger, T | 1 |
| Billman, GE | 1 |
| Clozel, JP; Hess, P; Véniant, M; Wolfgang, R | 1 |
| Clozel, JP; Osterrieder, W; Véniant, M | 1 |
1 review(s) available for mibefradil and Cardiovascular Stroke
| Article | Year |
|---|---|
Reappraisal of the importance of heart rate as a risk factor for cardiovascular morbidity and mortality.
Topics: Adrenergic beta-Antagonists; Benzimidazoles; Calcium Channel Blockers; Cardiovascular Diseases; Heart Rate; Humans; Hypertension; Mibefradil; Myocardial Infarction; Risk Factors; Tetrahydronaphthalenes | 1997 |
17 other study(ies) available for mibefradil and Cardiovascular Stroke
| Article | Year |
|---|---|
T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Body Weight; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiomyopathy, Dilated; Death, Sudden, Cardiac; Dihydropyridines; Disease Models, Animal; Female; Mibefradil; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Infarction; Myocytes, Cardiac; Nitrendipine; Nitrophenols; Organophosphorus Compounds; Patch-Clamp Techniques | 2009 |
Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Heart; Heart Rate; Mibefradil; Myocardial Infarction; Organ Size; Ramipril; Rats; Rats, Inbred SHR; Ventricular Pressure; Ventricular Remodeling | 2004 |
Infarct size-limiting properties of Ro 40-5967, a novel nondihydropyridine calcium channel, in anesthetized rats: comparison with verapamil.
Topics: Anesthesia; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Heart Rate; Hemodynamics; Male; Mibefradil; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Tetrahydronaphthalenes; Verapamil | 1995 |
The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog.
Topics: Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Dogs; Female; Heart; Heart Rate; Male; Mibefradil; Myocardial Infarction; Myocardial Ischemia; Myocardium; Tetrahydronaphthalenes; Verapamil | 1994 |
Cardioprotective activity of mibefradil.
Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Heart Failure; Hemodynamics; Humans; Mibefradil; Myocardial Infarction; Rats; Recurrence; Tetrahydronaphthalenes; Vasodilator Agents | 1998 |
Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats.
Topics: Analysis of Variance; Animals; Benzimidazoles; Calcium Channel Blockers; Drug Administration Schedule; Heart Failure; Hemodynamics; Male; Methoxamine; Mibefradil; Myocardial Contraction; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Tetrahydronaphthalenes; Time Factors; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Unique cardioprotective action of the new calcium antagonist mibefradil.
Topics: Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Glyburide; Heart; Heart Rate; Heart Ventricles; Mibefradil; Myocardial Infarction; Pressure; Swine; Tetrahydronaphthalenes; Verapamil | 1999 |
Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism.
Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Disease Progression; Enzyme Activation; Glyburide; Hemodynamics; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Mibefradil; Myocardial Infarction; Protein Kinase C; Rats; Rats, Sprague-Dawley; Risk Factors; Tetrahydronaphthalenes | 1999 |
Effects of mibefradil, a T-type calcium current antagonist, on electrophysiology of Purkinje fibers that survived in the infarcted canine heart.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Dogs; Electrophysiology; Male; Mibefradil; Myocardial Contraction; Myocardial Infarction; Purkinje Fibers | 1999 |
Mibefradil, a T-type calcium channel blocker, and abnormal rhythm in subacute myocardial infarction.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Humans; Mibefradil; Myocardial Infarction; Purkinje Fibers | 1999 |
Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
Topics: Adrenergic beta-Agonists; Aequorin; Amlodipine; Animals; Calcium; Calcium Channel Blockers; Chronic Disease; Heart; Heart Function Tests; Hemodynamics; Isometric Contraction; Isoproterenol; Male; Mibefradil; Myocardial Contraction; Myocardial Infarction; Myocardium; Papillary Muscles; Rats; Rats, Wistar; Verapamil | 1999 |
Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats.
Topics: Adrenergic beta-Agonists; Analysis of Variance; Animals; Blood Pressure; Calcium; Calcium Channel Blockers; Heart Failure; Heart Rate; Hemodynamics; In Vitro Techniques; Isoproterenol; Male; Mibefradil; Myocardial Contraction; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Ventricular Pressure | 1999 |
The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats.
Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Fibrosis; Heart; Heart Failure; Hemodynamics; Male; Mibefradil; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Ventricular Remodeling | 2000 |
Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Heart Failure; Hemodynamics; Hypertrophy, Left Ventricular; Male; Mibefradil; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Ventricular Remodeling; Verapamil | 2001 |
Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation.
Topics: Animals; Benzimidazoles; Binding Sites; Calcium Channel Blockers; Coronary Circulation; Diltiazem; Disease Susceptibility; Dogs; Dose-Response Relationship, Drug; Heart Rate; Mibefradil; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Physical Exertion; Tetrahydronaphthalenes; Ventricular Fibrillation; Verapamil | 1992 |
Ro 40-5967, in contrast to diltiazem, does not reduce left ventricular contractility in rats with chronic myocardial infarction.
Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Coronary Circulation; Depression, Chemical; Diltiazem; In Vitro Techniques; Male; Mibefradil; Myocardial Contraction; Myocardial Infarction; Perfusion; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes; Ventricular Function, Left | 1991 |
The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts.
Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Calcium Channels; Coronary Circulation; Depression, Chemical; Dose-Response Relationship, Drug; Female; Heart; Heart Failure; Hemodynamics; Male; Mibefradil; Myocardial Contraction; Myocardial Infarction; Rats; Rats, Inbred WKY; Receptors, Nicotinic; Tetrahydronaphthalenes; Tritium; Verapamil | 1990 |